Gross Profit (TTM) Chart

View Gross Profit (TTM) for CDNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 321.18M
March 31, 2026 281.75M
December 31, 2025 253.96M
September 30, 2025 239.56M
June 30, 2025 225.49M
March 31, 2025 231.76M
December 31, 2024 221.60M
September 30, 2024 203.12M
June 30, 2024 190.49M
March 31, 2024 170.65M
December 31, 2023 175.87M
September 30, 2023 188.90M
June 30, 2023 197.36M
March 31, 2023 206.10M
December 31, 2022 207.33M
September 30, 2022 206.91M
June 30, 2022 206.66M
March 31, 2022 203.92M
December 31, 2021 197.41M
September 30, 2021 184.85M
June 30, 2021 170.75M
March 31, 2021 147.31M
December 31, 2020 127.58M
September 30, 2020 110.92M
June 30, 2020 96.79M
Date Value
March 31, 2020 90.05M
December 31, 2019 80.31M
September 30, 2019 70.41M
June 30, 2019 60.39M
March 31, 2019 51.16M
December 31, 2018 42.68M
September 30, 2018 36.50M
June 30, 2018 31.48M
March 31, 2018 27.72M
December 31, 2017 26.45M
September 30, 2017 24.22M
June 30, 2017 23.75M
March 31, 2017 21.72M
December 31, 2016 19.31M
September 30, 2016 19.10M
June 30, 2016 17.16M
March 31, 2016 17.16M
December 31, 2015 17.87M
September 30, 2015 18.96M
June 30, 2015 19.26M
March 31, 2015 19.01M
December 31, 2014 18.26M
September 30, 2014 16.36M
June 30, 2014 14.33M
March 31, 2014 9.957M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Natera, Inc. 1.753B
Caris Life Sciences, Inc. 689.36M
Myriad Genetics, Inc. 525.10M
BioRestorative Therapies, Inc. 0.119M
Exagen, Inc. 41.70M